Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6526 AL 6540

A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease

Geldmacher DS, Fritsch T, McClendon MJ, Landreth G.

Arch Neurol. 2011 Jan;68(1):45-50. doi: 10.1001/archneurol.2010.229. Epub 2010 Sep 13.

Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy

Olazarán J, Reisberg B, Clare L, Cruz I, Peña-Casanova J, Del Ser T, Woods B, Beck C, Auer S, Lai C, Spector A, Fazio S, Bond J, Kivipelto M, Brodaty H, Rojo JM, Collins H, Teri L, Mittelman M, Orrell M, Feldman HH, Muñiz R.

Dement Geriatr Cogn Disord. 2010;30(2):161-78. doi: 10.1159/000316119. Epub 2010 Sep 10.

Why is the New York Times writing so much about Alzheimer's disease therapies?

Bartfai T.

ScientificWorldJournal. 2010 Sep 14;10:1886-9. doi: 10.1100/tsw.2010.185.

Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease

Brioni JD, Esbenshade TA, Garrison TR, Bitner SR, Cowart MD.

J Pharmacol Exp Ther. 2011 Jan;336(1):38-46. doi: 10.1124/jpet.110.166876. Epub 2010 Sep 23.

Naltrexone effects in patients with dementia

Read SL.

Am J Psychiatry. 2010 Oct;167(10):1278-9. doi: 10.1176/appi.ajp.2010.09111630.

Do patients diagnosed with Alzheimer's disease benefit from a psycho-educational programme for family caregivers? A randomised controlled study

de Rotrou J, Cantegreil I, Faucounau V, Wenisch E, Chausson C, Jegou D, Grabar S, Rigaud AS.

Int J Geriatr Psychiatry. 2011 Aug;26(8):833-42. doi: 10.1002/gps.2611. Epub 2010 Oct 4.

Exercise rehabilitation on home-dwelling patients with Alzheimer's disease--a randomized, controlled trial. Study protocol

Pitkala KH, Raivio MM, Laakkonen ML, Tilvis RS, Kautiainen H, Strandberg TE.

Trials. 2010 Oct 6;11:92. doi: 10.1186/1745-6215-11-92.

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease

Tzimopoulou S, Cunningham VJ, Nichols TE, Searle G, Bird NP, Mistry P, Dixon IJ, Hallett WA, Whitcher B, Brown AP, Zvartau-Hind M, Lotay N, Lai RY, Castiglia M, Jeter B, Matthews JC, Chen K, Bandy D, Reiman EM, Gold M, Rabiner EA, Matthews PM.

J Alzheimers Dis. 2010;22(4):1241-56. doi: 10.3233/JAD-2010-100939.

Modern care for patients with Alzheimer disease: rationale for early intervention

Galluzzi KE, Appelt DM, Balin BJ.

J Am Osteopath Assoc. 2010 Sep;110(9 Suppl 8):S37-42.

Mindfulness effects on caregiver stress: should we expect more?

Khalsa DS.

J Altern Complement Med. 2010 Oct;16(10):1025-6. doi: 10.1089/acm.2010.0431.

Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results

Yaffe K.

JAMA. 2010 Nov 3;304(17):1952-3. doi: 10.1001/jama.2010.1625.

Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease

Small G, Bullock R.

Alzheimers Dement. 2011 Mar;7(2):177-84. doi: 10.1016/j.jalz.2010.03.016. Epub 2010 Nov 5.

Qualitative analysis of therapeutic light effects on global function in Alzheimer's disease

Nowak L, Davis J.

West J Nurs Res. 2011 Nov;33(7):933-52. doi: 10.1177/0193945910386248. Epub 2010 Nov 17.

Needs in early onset dementia: A qualitative case from the NeedYD study

Bakker C, de Vugt ME, Vernooij-Dassen M, van Vliet D, Verhey FR, Koopmans RT.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):634-40. doi: 10.1177/1533317510385811.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias